Press Announcements > FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims

Press Announcements > FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims



FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims



The U.S. Food and Drug Administration and the Federal Trade Commission today posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal. Continue reading.